Work

116 Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: data from phase 1 and phase 2 studies

Year: 2021

Type: article

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2021-esgo.8

Authors: J. Strauss, F. Braiteh, E. Calvo Aller, M. De Miguel, A. Cervantes, W.J. Edenfield, T. LI, M.A. Rasschaert, T.W. Park-Simon, F.L. Munoz, L. Paz-Ares, A. Spira, G. Jehl, I. Dussault, L. Ojalvo, J. Gulley, S. Allan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Comprehensive Cancer Centers of Nevada, Universitat de València, INCLIVA Health Research Institute, Prisma Health, UC Davis Comprehensive Cancer Center, Antwerp University Hospital, Medizinische Hochschule Hannover, Instituto Ramón y Cajal de Investigación Sanitaria, Centro de Investigación Biomédica en Red de Cáncer, Hospital Universitario Ramón y Cajal, Hospital Universitario 12 De Octubre, Virginia Cancer Specialists, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Univerzita Karlova v Praze, Agentura Pro Zdravotnický Výzkum České Republiky

Awards: G331001653, G36803724, G6628790877, G7569762881, G867049796

OpenAlex ID: W3207388141

FWCI:

Cites:

Cited by:

Related to: 10